Ishita Drugs and Industries Limited
Ishita Drugs and Industries Limited
Share · INE806D01016 (XBOM)
Overview
No Price
Closing Price XBOM 28.01.2026: 68,07 INR
28.01.2026 05:08
Current Prices from Ishita Drugs and Industries Limited
ExchangeTickerCurrencyLast TradePriceDaily Change
XBOM: MSE
MSE
ISHITADR.BO
INR
28.01.2026 05:08
68,07 INR
0,00 INR
Share Float & Liquidity
Free Float 37,52 %
Shares Float 1,12 M
Shares Outstanding 2,99 M
Company Profile for Ishita Drugs and Industries Limited Share
Ishita Drugs & Industries Ltd. engages in the manufacturing of basic drugs. It offers active pharma ingredients, drug intermediates, fine chemicals, and finished dosage forms. The company was founded by Jagdishprasad Gokulchand Agrawal on February 5, 1992 and is headquartered in Ahmedabad, India.
AI Analysis of Ishita Drugs and Industries Limited
Click any analysis below to get instant AI insights from finAgent
Latest AI Analyses of Ishita Drugs and Industries Limited
No AI threads available for this company yet.

Company Data

Name Ishita Drugs and Industries Limited
Company Ishita Drugs and Industries Limited
Website http://www.ishitadrugs.com
Primary Exchange XBOM MSE
ISIN INE806D01016
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Jagdishprasad Gokulchand Agrawal
Market Capitalization 204 Mio
Country India
Currency INR
Employees 0,0 T
Address 401, 3rd Eye II, Ahmedabad

Ticker Symbols

Name Symbol
MSE ISHITADR.BO
More Shares
Investors who hold Ishita Drugs and Industries Limited also have the following shares in their portfolio:
CASINO 11/21 MTN
CASINO 11/21 MTN Bond
LEVERAGE SHA ETP 2071
LEVERAGE SHA ETP 2071 ETN
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2026